
Celgene buys Delinia for $300mm plus earn-outs
Executive Summary
Celgene Corp. is paying $300mm up front to acquire one-year-old private biotech Delinia Inc. The agreement also includes an additional $475mm in potential earn-out payments.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com